The RNA sequencing of recurrent GBM revealed the presence of FGFR3 exon17-TACC3 exon 10 (Catalog of Somatic Mutations in Cancer mutation identifier COSF1434) fusion (Figure 3). This evidence concerns the gene FGFR3 and glioblastoma.